The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Magnesium Oxide 400mg
Magnesium Oxide 400mg · MAGNESIUM OXIDE 400 mg/1 · Tablet · Oral · Allegiant Health
NDC 69168-0174-06 · 120 TABLET in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- M001
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Magnesium Oxide 400mg (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Allegiant Health | MAGNESIUM OXIDE 400 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Magnesium Oxide 400mg — NDC 69168-0174-06," retrieved September 3, 2026, https://drugdashboards.com/drug/69168017406.
Free to cite with attribution — see how the data is put together.